U.S. ebola treatment center clinical laboratory support

Journal of Clinical Microbiology

Volumn 54, Issue 4, 2016, Pages 1031-1035

  Jelden, Katelyn C ^a   Iwen, Peter C ^b,c   Herstein, Jocelyn J ^a   Biddinger, Paul D ^d,e   Kraft, Colleen S ^f   Saiman, Lisa ^g,h   Smith, Philip W ^a   Hewlett, Angela L ^a   Gibbs, Shawn G ^a,i   Lowe, John J ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c Nebraska Public Health Laboratory   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g Department of Medicine   (United States)

^h NEW YORK PRESBYTERIAN HOSPITAL   (United States)

ⁱ INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOSAFETY; CLINICAL LABORATORY; EBOLA HEMORRHAGIC FEVER; EBOLA TREATMENT CENTER; HEALTH CARE FACILITY; HEALTH CARE SURVEY; INTENSIVE CARE; PATIENT CARE PLANNING; POINT OF CARE TESTING; PRIORITY JOURNAL; PUBLIC HEALTH LABORATORY; UNITED STATES; DIAGNOSTIC TEST; HAZARDOUS WASTE; HEMORRHAGIC FEVER, EBOLA; HUMAN; LABORATORY; LABORATORY TECHNIQUE; PROCEDURES; QUESTIONNAIRE; STANDARDS;

CLINICAL LABORATORY TECHNIQUES; CONTAINMENT OF BIOHAZARDS; DIAGNOSTIC TESTS, ROUTINE; HEMORRHAGIC FEVER, EBOLA; HUMANS; LABORATORIES; SURVEYS AND QUESTIONNAIRES; UNITED STATES;

EID: 84962580796     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02905-15     Document Type: Article

References (17)

1. Gostin LO, Hodge JG, Jr, Burris S. 2014. Is the United States prepared for Ebola? JAMA 312:2497-2498. http://dx.doi.org/10.1001/jama.2014.15041.
2. Santora M. 24 October 2014. New York doctor, back from Africa, is sick with Ebola, p A1. New York Times, New York, NY.
3. HHS. 2015. HHS invests in enhancing domestic preparedness efforts for Ebola. HHS, Washington, DC.
4. CDC. 2015. Interim guidance for U.S. hospital preparedness for patients under investigation (PUIs) or with confirmed Ebola virus disease (EVD): A framework for a tiered approach. CDC, Atlanta, GA.
5. CDC. 2015. Guidance for collection, transport and submission of specimens for Ebola virus testing. CDC, Atlanta, GA.
6. Lyon GM, Mehta AK, Varkey JB, Brantly K, Plyler L, McElroy AK, Kraft CS, Towner JS, Spiropoulou C, Ströher U, Uyeki TM, Ribner BS. 2014. Clinical care of two patients with Ebola virus disease in the United States. N Engl J Med 371:2402-2409. http://dx.doi.org/10.1056/NEJMoa1409838.
7. Johnson DW, Sullivan JN, Piquette CA, Hewlett AL, Bailey KL, Smith PW, Kalil AC, Lisco SJ. 2015. Lessons learned: critical care management of patients with Ebola in the United States. Crit Care Med 43:1157-1164. http://dx.doi.org/10.1097/CCM.0000000000000935.
8. CDC. 2015. Guidance for U.S. laboratories for managing and testing routine clinical specimens when there is a concern about Ebola virus disease. CDC, Atlanta, GA.
9. Iwen PC, Garrett JL, Gibbs SG, Lowe JJ, Herrera VL, Sambol AR, Stiles K, Wisecarver JL, Salerno KJ, Pirruccello SJ, Hinrichs SH. 2014. An integrated approach to laboratory testing for patients with Ebola virus disease. Lab Med 45:e146-e151. http://dx.doi.org/10.1309/LMTULFM62W3RKMYI.
10. Fowler RA, Fletcher T, Fischer WA, II, Lamontagne F, Jacob S, Brett-Major D, Lawler JV, Jacquerioz FA, Houlihan C, O'Dempsey T, Ferri M, Adachi T, Lamah MC, Bah EI, Mayet T, Schieffelin J, McLellan SL, Senga M, Kato Y, Clement C, Mardel S, Vallenas Bejar De Villar RC, Shindo N, Bausch D. 2014. Caring for critically ill patients with Ebola virus disease. Perspectives from West Africa. Am J Respir Crit Care Med 190:733-737. http://dx.doi.org/10.1164/rccm.201408-1514CP.
11. CDC. 2014. Interim guidance for preparing Ebola treatment centers. CDC, Atlanta, GA.
12. Iwen PC, Smith PW, Hewlett AL, Kratochvil CJ, Lisco SJ, Sullivan JN, Gibbs SG, Lowe JJ, Fey PD, Herrera VL, Sambol AR, Wisecarver JL, Hinrichs SH. 2015. Safety considerations in the laboratory testing of specimens suspected or known to contain Ebola virus. Am J Clin Pathol 143: 4-5. http://dx.doi.org/10.1309/AJCP26MIFUIETBPL.
13. Hill CE, Burd EM, Kraft CS, Ryan EL, Duncan A, Winkler AM, Cardella JC, Ritchie JC, Parslow TG. 2014. Laboratory test support for Ebola patients within a high-containment facility. Lab Med 45:e109-e111. http://dx.doi.org/10.1309/LMTMW3VVN20HIFS.
14. Fusco F, Schilling S, Puro V, Brodt H, Follin P, Jarhall B, Bannister B, Maltezou H, Thomsen G, Brouqui P. 2009. EuroNID checklists for the assessment of high-level isolation units and referral centres for highly infectious diseases: results from the pilot phase of a European survey. Clin Microbiol Infect 15:711-719. http://dx.doi.org/10.1111/j.1469-0691.2009.02874.x.
15. HHS. 2009. Section IV-laboratory biosafety level criteria, p 30-59. In Chosewood LC, Wilson DE (ed), Biosafety in microbiological and biomedical laboratories, 5th ed. US Department of Health and Human Services, Washington, DC. http://www.cdc.gov/biosafety/publications/bmbl 5/BMBL.pdf.
16. Kortepeter MG, Martin JW, Rusnak JM, Cieslak TJ, Warfield KL, Anderson EL, Ranadive MV. 2008. Managing potential laboratory exposure to Ebola virus by using a patient biocontainment care unit. Emerg Infect Dis 14:881-887. http://dx.doi.org/10.3201/eid1406.071489.
17. Thiberville SD, Schilling S, De Iaco G, Fusco FM, Thomson G, Maltezou HC, Gottschalk R, Brodt RH, Bannister B, Puro V, Ippolito G, Brouqui P, EuroNHID Working Group. 2012. Diagnostic issues and capabilities in 48 isolation facilities in 16 European countries: data from EuroNHID surveys. BMC Res Notes 5:527. http://dx.doi.org/10.1186/1756-0500-5-527.